From apparel to clinical trials: Lululemon Founder Commits $100 Million to Find Cure for FSHD

VANCOUVER, B.C. – The world’s most successful entrepreneurs are often willing to share how lessons learned and resilience have shaped their business sense, but few transcend their successes to optimistically forge a path to overcome one’s biggest challenge – their health. Going public with his own story, Wilson, who was diagnosed with Facioscapulohumeral muscular dystrophy type 2 (FSHD2) at age 32, announced he has committed $100 million and created a new venture, Solve FSHD, with the objective of finding a cure for FSHD by 2027, targeing the underlying genetic cause or improving muscle function and growth.